2.90Open3.60Pre Close3 Volume9 Open Interest49.00Strike Price870.00Turnover137.54%IV3.26%PremiumDec 6, 2024Expiry Date1.26Intrinsic Value100Multiplier2DDays to Expiry1.64Extrinsic Value100Contract SizeAmericanOptions Type0.6126Delta0.0684Gamma17.33Leverage Ratio-0.5072Theta0.0018Rho10.62Eff Leverage0.0156Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet